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Background
Tumor endothelium marker 8 (TEM8) was discovered by
St Croix, et. al. as one of nine gene products preferentially
upregulated in the tumor-associated vs. normal endothe-
lium [1]. Interestingly, TEM8 has also been identified as a
tumor restricted antigen in triple negative breast cancers
(TNBC) [2,3]; a clinical entity associated with a particu-
larly poor prognosis. Being null for HER2, estrogen and
progesterone receptors, targeted therapies for TNBC are
quite limited.
Purpose
To use T cells expressing TEM8-specific chimeric anti-
gen receptors (CAR) as a novel approach to target both
TNBC cells and their tumor-associated vasculature.
Methods/ results
We used in silico design to construct a novel TEM8-speci-
fic CAR molecule. The antigen recognition exodomain
consisted of a single chain variable fragment based on the
TEM8-specific monoclonal antibody, SB5. The signaling
endodomain consisted of the costimulatory molecule
CD28 and CD3-zeta chain. The encoding DNA was codon
optimized, synthesized and then sequence verified. We
used a retroviral transduction system to express the TEM8
CAR transgene on HEK 293T, then on primary T cells.
Approximately 70% of primary human T cells expressed
the TEM8 CAR, as detected by flow cytometry. The
expression of TEM8 was characterized using flow cytome-
try and western blot on a battery of TNBC lines, TEM8
transduced (modest and high expressers) cell lines as well
as TEM8 negative cell lines. TEM8 CAR T cells recog-
nized and killed TEM8 positive target cells in an antigen-
dependent fashion in 51Cr release assays and secreted
immunostimulatory cytokines upon encounter of TEM8
positive cells. There was no reactivity against TEM8 nega-
tive cell lines. No cytotoxicity or cytokine release was
exhibited by T cells expressing an irrelevant (CD19 specific)
CAR or non-transduced T cells from the same blood
donor. We are currently testing this strategy in a vascular-
ized orthotopic breast cancer murine model.
Conclusion
TEM8 specific CAR T cells could serve as a tumor and
vascular-targeted immunotherapeutic modality for triple-
negative breast cancer.
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